Anti-scarring effects of conbercept on human Tenon’s fibroblasts: comparisons with bevacizumab

BACKGROUND: Safely inhibiting the formation of scar in the glaucoma filtration surgery (GFS) has always been an issue for clinical glaucoma doctors. Anti-vascular endothelial growth factor (VEGF) agents can reduce angiogenesis, and anti-placental growth factor (PIGF) agents can affect reactive glios...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuo, Lei, Zhu, Shaopin, Gu, Shengjie, Xu, Xun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131424/
https://www.ncbi.nlm.nih.gov/pubmed/37101202
http://dx.doi.org/10.1186/s12886-023-02914-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131424/
https://www.ncbi.nlm.nih.gov/pubmed/37101202
http://dx.doi.org/10.1186/s12886-023-02914-4

Ejemplares similares